ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
Bayer
AstraZeneca
Myeloid Therapeutics
SEED Therapeutics, Inc.
DualityBio Inc.
NextCure, Inc.
Tanabe Pharma America, Inc.
Merck Sharp & Dohme LLC
Eli Lilly and Company
Merck Sharp & Dohme LLC
Bolt Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Yuhan Corporation
AstraZeneca
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Instituto do Cancer do Estado de São Paulo